Alle Storys
Folgen
Keine Story von Deutsche Effecten- und Wechsel-Beteiligungsges. AG mehr verpassen.

Deutsche Effecten- und Wechsel-Beteiligungsges. AG

DEWB forging ahead with the focusing of its investment portfolio - expansion of assets under management planned

Jena (euro adhoc) -

  ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
  the content of this announcement.
balance
DEWB AG, Jena, is consistently continuing to
pursue its strategy of focusing its investment portfolio more 
strongly. The company´s aim is to establish itself as leading 
independent provider of investment capital in the optics, 
optical-related technologies and sensor systems sectors. To this end,
in addition to the targeted orientation of the portfolio, there are 
also plans to expand the assets under management, with the 
medium-term goal being to increase these from the current 50 million 
euros to over 100 million euros. In this context, the largest 
proportion of the growth is expected to be generated from the 
enhancement of the value of the investment holdings.
Course of business As at the report date 30 June 2007 DEWB held 
twelve investment holdings. The value of the investment portfolio in 
the balance sheet is 42.0 million euros and has increased by 1.2 
million euros compared with 31 December 2006 (40.8 million euros) 
through investments in the existing portfolio. In the current 
positive economic environment the investment holdings have achieved 
good development and are reporting increasing order intakes.
As planned, DEWB AG did not sell any of the shares from its 
investment portfolio in the first half year 2007. DEWB AG is 
therefore posting a balanced gross result for the period under 
review. The EBIT for the period covered by the report is -0.7 million
euros. The result after taxes is -0.8 million euros, corresponding to
-0.05 euros per share. It should be noted in this respect that the 
lack of continuity of the sales transactions, a typical feature of 
the investment business, leads to fluctuations in sales and income.
The balance sheet total as at 30 June 2007 has fallen slightly 
compared with the end of 2006 (-1.1 %). Liquid assets have reduced by
2.2 million euros against 31 December 2006 as a result of investments
in the portfolio and operational payments. The shareholders´ equity 
was down slightly to 38.4 million euros due to the result for the 
period. The shareholders´ equity quota per share was 2.52 euros (31 
December 2006: 2.57 euros per share).
Outlook The development of the portfolio companies in value terms 
forms the operational focus of DEWB during this fiscal year and the 
intention is to achieve this through active management amongst other 
things. To this end DEWB is on the one side pursuing M&A options for 
individual investments in order to help them to either achieve 
critical mass, improve their market position or realise strategic 
additions on the technology side. At the same time, DEWB AG will be 
examining exit opportunities during the remainder of 2007.
DEWB also sees attractive investment opportunities which will fit 
into the investment profile of optics, optical-related technologies 
and sensor systems and in this way make a contribution towards the 
realisation of the investment company´s overall strategy. The latest 
transaction, the investment in the Jena-based company Zenteris GmbH, 
is a further step along the way to the realisation of this concept. 
The additional expansion of the investment funds is intended to 
ensure that DEWB is able to exploit attractive investment 
opportunities independently of cash inflows from sales of shares.
About DEWB Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
(DEWB AG, Prime Standard, Securities No.: 804100 / ISIN: 
DE0008041005) is an investment company that specialises in young and 
established medium-sized companies. The focus of our investments is 
on strong growth companies from the areas of optics, optical-related 
technologies and sensor systems for which we provide support through 
shareholders´ equity, expertise in corporate development and our 
sector network. Our regional focus lies in the German speaking 
countries (D, A, CH). Since 1997 we have invested more than 300 
million Euros in 53 companies and realized more than 400 million 
Euros through 32 exits, eight of which were in the form of IPOs. The 
company is located in Jena, one of the most successful technology and
science regions in Germany, with a long tradition in the field of 
optical technologies and one of the most important European centres 
for Photonics.
end of announcement                               euro adhoc 09.08.2007 10:00:00

Further inquiry note:

Mirko Wäckerle
DEWB AG
Phone: +49 (0) 3641 573 3600
Fax: +49 (0) 3641 573 3610
E-Mail: ir@dewb-vc.com
www.dewb-vc.com

Branche: Financial & Business Services
ISIN: DE0008041005
WKN: 804100
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / official dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse München / free trade

Weitere Storys: Deutsche Effecten- und Wechsel-Beteiligungsges. AG
Weitere Storys: Deutsche Effecten- und Wechsel-Beteiligungsges. AG
  • 08.08.2007 – 10:48

    bm-t and DEWB acquire majority shareholding in Zenteris

    ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. merger, acquisition and takeover Erfurt/Jena (euro adhoc) - bm-t beteiligungsmanagement thüringen gmbh (bm-t), Erfurt and Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG (DEWB), Jena took a joint stake in Zenteris GmbH (Zenteris) at the end of July 2007. In an initial round of financing, ...

  • 03.05.2007 – 10:21

    DEWB´s portfolio company NOXXON closes 37 mill. EUR financing round

    ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. investments/NOXXON Financing Round Jena/Berlin (euro adhoc) - Jena/Berlin, May 3, 2007 - DEWB´s portfolio company NOXXON Pharma AG (NOXXON), developer of mirror image oligonucleotide therapeutics termed Spiegelmers®, announced today the successful ...

  • 17.04.2007 – 16:03

    euro adhoc: Deutsche Effecten- und Wechsel-Beteiligungsges. AG / Director's Dealings

    Notification concerning transactions by persons discharging managerial responsibilities pursuant to section 15a of the WpHG, transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. 17.04.2007 ausserboerslich (euro adhoc) - Details of the person subject to the ...